Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Corticosteroid Injections for Joint Pain market report explains the definition, types, applications, major countries, and major players of the Corticosteroid Injections for Joint Pain market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Allergan
Zimmer Biomet
Flexion Therapeutics
Sanofi
Ferring
SEIKAGAKU
Chugai Pharma
Pfizer
Bioventus
Anika Therapeutics
By Type:
Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Corticosteroid Injections for Joint Pain Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Corticosteroid Injections for Joint Pain Outlook to 2028- Original Forecasts
-
2.2 Corticosteroid Injections for Joint Pain Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Corticosteroid Injections for Joint Pain Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Corticosteroid Injections for Joint Pain Market- Recent Developments
-
6.1 Corticosteroid Injections for Joint Pain Market News and Developments
-
6.2 Corticosteroid Injections for Joint Pain Market Deals Landscape
7 Corticosteroid Injections for Joint Pain Raw Materials and Cost Structure Analysis
-
7.1 Corticosteroid Injections for Joint Pain Key Raw Materials
-
7.2 Corticosteroid Injections for Joint Pain Price Trend of Key Raw Materials
-
7.3 Corticosteroid Injections for Joint Pain Key Suppliers of Raw Materials
-
7.4 Corticosteroid Injections for Joint Pain Market Concentration Rate of Raw Materials
-
7.5 Corticosteroid Injections for Joint Pain Cost Structure Analysis
-
7.5.1 Corticosteroid Injections for Joint Pain Raw Materials Analysis
-
7.5.2 Corticosteroid Injections for Joint Pain Labor Cost Analysis
-
7.5.3 Corticosteroid Injections for Joint Pain Manufacturing Expenses Analysis
8 Global Corticosteroid Injections for Joint Pain Import and Export Analysis (Top 10 Countries)
-
8.1 Global Corticosteroid Injections for Joint Pain Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Corticosteroid Injections for Joint Pain Export by Region (Top 10 Countries) (2017-2028)
9 Global Corticosteroid Injections for Joint Pain Market Outlook by Types and Applications to 2022
-
9.1 Global Corticosteroid Injections for Joint Pain Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Knee & Ankle Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hip Joint Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Shoulder & Elbow Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Facet Joints of the Spine Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Corticosteroid Injections for Joint Pain Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Corticosteroid Injections for Joint Pain Market Analysis and Outlook till 2022
-
10.1 Global Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.2.2 Canada Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.2.3 Mexico Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.2 UK Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.3 Spain Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.4 Belgium Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.5 France Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.6 Italy Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.7 Denmark Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.8 Finland Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.9 Norway Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.10 Sweden Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.11 Poland Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.12 Russia Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.3.13 Turkey Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.2 Japan Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.3 India Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.4 South Korea Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.5 Pakistan Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.6 Bangladesh Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.7 Indonesia Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.8 Thailand Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.9 Singapore Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.10 Malaysia Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.11 Philippines Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.4.12 Vietnam Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.2 Colombia Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.3 Chile Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.4 Argentina Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.5 Venezuela Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.6 Peru Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.7 Puerto Rico Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.5.8 Ecuador Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.6.2 Kuwait Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.6.3 Oman Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.6.4 Qatar Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.6.5 Saudi Arabia Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.6.6 United Arab Emirates Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.7.2 South Africa Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.7.3 Egypt Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.7.4 Algeria Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Corticosteroid Injections for Joint Pain Consumption (2017-2022)
-
10.8.2 New Zealand Corticosteroid Injections for Joint Pain Consumption (2017-2022)
11 Global Corticosteroid Injections for Joint Pain Competitive Analysis
-
11.1 Allergan
-
11.1.1 Allergan Company Details
-
11.1.2 Allergan Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Allergan Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.1.4 Allergan Corticosteroid Injections for Joint Pain Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Zimmer Biomet
-
11.2.1 Zimmer Biomet Company Details
-
11.2.2 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.2.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Flexion Therapeutics
-
11.3.1 Flexion Therapeutics Company Details
-
11.3.2 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.3.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sanofi
-
11.4.1 Sanofi Company Details
-
11.4.2 Sanofi Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sanofi Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.4.4 Sanofi Corticosteroid Injections for Joint Pain Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Ferring
-
11.5.1 Ferring Company Details
-
11.5.2 Ferring Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Ferring Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.5.4 Ferring Corticosteroid Injections for Joint Pain Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 SEIKAGAKU
-
11.6.1 SEIKAGAKU Company Details
-
11.6.2 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.6.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Chugai Pharma
-
11.7.1 Chugai Pharma Company Details
-
11.7.2 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Chugai Pharma Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.7.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pfizer
-
11.8.1 Pfizer Company Details
-
11.8.2 Pfizer Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pfizer Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.8.4 Pfizer Corticosteroid Injections for Joint Pain Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Bioventus
-
11.9.1 Bioventus Company Details
-
11.9.2 Bioventus Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Bioventus Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.9.4 Bioventus Corticosteroid Injections for Joint Pain Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Anika Therapeutics
-
11.10.1 Anika Therapeutics Company Details
-
11.10.2 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
11.10.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Corticosteroid Injections for Joint Pain Market Outlook by Types and Applications to 2028
-
12.1 Global Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Knee & Ankle Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Hip Joint Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Shoulder & Elbow Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Facet Joints of the Spine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Corticosteroid Injections for Joint Pain Market Analysis and Outlook to 2028
-
13.1 Global Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.2.2 Canada Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.2.3 Mexico Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.2 UK Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.3 Spain Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.4 Belgium Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.5 France Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.6 Italy Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.7 Denmark Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.8 Finland Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.9 Norway Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.10 Sweden Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.11 Poland Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.12 Russia Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.3.13 Turkey Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.2 Japan Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.3 India Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.4 South Korea Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.8 Thailand Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.9 Singapore Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.11 Philippines Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.2 Colombia Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.3 Chile Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.4 Argentina Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.6 Peru Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.6.3 Oman Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.6.4 Qatar Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.7.2 South Africa Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.7.3 Egypt Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.7.4 Algeria Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Corticosteroid Injections for Joint Pain Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Corticosteroid Injections for Joint Pain
-
Figure of Corticosteroid Injections for Joint Pain Picture
-
Table Global Corticosteroid Injections for Joint Pain Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Corticosteroid Injections for Joint Pain Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Knee & Ankle Consumption and Growth Rate (2017-2022)
-
Figure Global Hip Joint Consumption and Growth Rate (2017-2022)
-
Figure Global Shoulder & Elbow Consumption and Growth Rate (2017-2022)
-
Figure Global Facet Joints of the Spine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Table North America Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure United States Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Canada Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Mexico Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table Europe Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure Germany Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure UK Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Spain Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Belgium Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure France Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Italy Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Denmark Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Finland Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Norway Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Sweden Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Poland Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Russia Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Turkey Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table APAC Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure China Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Japan Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure India Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure South Korea Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Thailand Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Singapore Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Philippines Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table South America Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure Brazil Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Colombia Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Chile Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Argentina Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Peru Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table GCC Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure Bahrain Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Oman Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Qatar Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table Africa Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure Nigeria Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure South Africa Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Egypt Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure Algeria Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table Oceania Corticosteroid Injections for Joint Pain Consumption by Country (2017-2022)
-
Figure Australia Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Corticosteroid Injections for Joint Pain Consumption and Growth Rate (2017-2022)
-
Table Allergan Company Details
-
Table Allergan Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Allergan Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Zimmer Biomet Company Details
-
Table Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zimmer Biomet Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Zimmer Biomet Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Flexion Therapeutics Company Details
-
Table Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Flexion Therapeutics Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Sanofi Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Ferring Company Details
-
Table Ferring Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Ferring Corticosteroid Injections for Joint Pain Product Portfolio
-
Table SEIKAGAKU Company Details
-
Table SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table SEIKAGAKU Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table SEIKAGAKU Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Chugai Pharma Company Details
-
Table Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chugai Pharma Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Chugai Pharma Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Pfizer Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Bioventus Company Details
-
Table Bioventus Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioventus Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Bioventus Corticosteroid Injections for Joint Pain Product Portfolio
-
Table Anika Therapeutics Company Details
-
Table Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anika Therapeutics Corticosteroid Injections for Joint Pain Main Business and Markets Served
-
Table Anika Therapeutics Corticosteroid Injections for Joint Pain Product Portfolio
-
Figure Global Knee & Ankle Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hip Joint Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Shoulder & Elbow Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Facet Joints of the Spine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Table North America Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure United States Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure Germany Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure China Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure Brazil Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Corticosteroid Injections for Joint Pain Consumption Forecast by Country (2022-2028)
-
Figure Australia Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Corticosteroid Injections for Joint Pain Consumption Forecast and Growth Rate (2022-2028)
-
